Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Anticancer Research|November 11, 2006
Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor modelsM Tejeda, D Gaál, L Hullán, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Synthesis and conformational studies of poly(L-lysine) based branched polypeptides with Ser and Glu/Leu in the side chainsG Mezö, J Reményi, J Kajtár, et al.Anticancer Research|January 30, 2008
Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor modelsM Tejeda, D Gaál, L Hullán, et al.Mechanisms of Ageing and Development|May 1, 1977
Modulative effect of endogenous granuloid inhibitors on cell proliferationA Balázs, T Klupp, G Zsila, et al.Toxicology and Applied Pharmacology|September 30, 1984
Effects of bacterial endotoxins and their detoxified derivatives on serum and liver lipids in miceD Gaál, T Kremmer, Z Bálint, et al.Anticancer Research|August 5, 2006
A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor modelsM Tejeda, D Gaál, L Hullán, et al.Annals of Nuclear Medicine|November 1, 1995
Gamma scintigraphy of 111In-labelled branched chain polypeptides (BCP) with a poly(L-lysine) backbone in mice with mammary carcinoma: effect of charge on biodistribution and tumour imaging potentialM V Pimm, A C Perkins, S J Gribben, et al.Cancer Detection and Prevention|January 1, 1996
In vivo studies of the new gonadotropin-releasing hormone antagonist--copolymer conjugates having antitumor activityB Vincze, I Pályi, D Gaál, et al.Bioconjugate Chemistry|September 30, 1999
Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicityF Hudecz, M V Pimm, E Rajnavölgyi, et al.Pageof 3